Related references
Note: Only part of the references are listed.High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation
Barbara Kern et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
Zobair M. Younossi et al.
TRANSPLANTATION (2019)
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
David Goldberg et al.
GASTROENTEROLOGY (2017)
Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease
C. R. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System
D. K. Filippiadis et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients Applicability of the BCLC Staging System
Luciana Kikuchi et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
Zobair Younossi et al.
GASTROENTEROLOGY (2016)
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Arndt Weinmann et al.
BMC CANCER (2015)
Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis
Rohan Chaminda Siriwardana et al.
BMC GASTROENTEROLOGY (2015)
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
Ryosuke Tateishi et al.
JOURNAL OF GASTROENTEROLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): A case report
Jason Salsamendi et al.
JOURNAL OF RADIOLOGY CASE REPORTS (2015)
Hepatotoxicity Secondary to Chemotherapy
Alla Grigorian et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2014)
Competing risks regression for clustered data
Bingqing Zhou et al.
BIOSTATISTICS (2012)
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
Srinevas K. Reddy et al.
HEPATOLOGY (2012)
Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads
Boris Guiu et al.
JOURNAL OF HEPATOLOGY (2012)
Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival
Antoine Bouvier et al.
EUROPEAN RADIOLOGY (2011)
Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Toshifumi Wakai et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH
T. Ohki et al.
GUT (2009)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Share Paper
